Product Description: Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody. Sibeprenlimab can inhibit APRIL. Sibeprenlimab can be used for the research of IgA nephropathy (IgAN)[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Mohit Mathur, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers. Kidney Int Rep. 2022 Feb 8;7(5):993-1003.
CAS Number: 2382896-07-1
Molecular Weight: N/A
Compound Purity: 99.77
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Others